Thomas E Clancy

5PUBLICATIONS
75CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 21, 2023
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer.

Lestat R Ali, Patrick J Lenehan, Victoire Cardot-Ruffino

|Jul 18, 2023
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer.

Harshabad Singh, Rachel B Keller, Kevin S Kapner

|Apr 13, 2023
Surgical Management of Pancreatic Neuroendocrine Tumors.

Megan L Sulciner, Thomas E Clancy

|Dec 02, 2022
Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity.

Hannah L Williams, Andressa Dias Costa, Jinming Zhang

|Sep 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer.

Andressa Dias Costa, Sara A Väyrynen, Akhil Chawla

Pageof 1

Frequent Collaborators

4 joint publications

Brian M Wolpin

4 joint publications

Jonathan A Nowak

3 joint publications

Andressa Dias Costa

3 joint publications

Andrew J Aguirre